Intuitive Surgical, Inc. (ISRG) reported $2.44 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 21.4%. EPS of $2.19 for the same period compares to $1.78 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $2.35 billion, representing a surprise of +3.93%. The company delivered an EPS surprise of +14.06%, with the consensus EPS estimate being $1.92.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Intuitive Surgical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Da Vinci Surgical System Installed Base: 10,488 versus the four-analyst average estimate of 10,427.
- Revenue- Product (Instruments and accessories and Systems): $2.05 billion compared to the $1.96 billion average estimate based on seven analysts. The reported number represents a change of +21% year over year.
- Revenue- Services: $391.2 million versus $368.86 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +23.3% change.
- Revenue- Systems: $574.7 million versus $516.21 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +28.2% change.
- Revenue- Instruments and accessories: $1.47 billion versus $1.44 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +18.5% change.
View all Key Company Metrics for Intuitive Surgical here>>>
Shares of Intuitive Surgical have returned +0.2% over the past month versus the Zacks S&P 500 composite's +5.9% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
